Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Quality of Life in Cancer Patients Undergoing Anticoagulant Treatment for Venous Thromboembolism: The Quavitec Study

Dominique Farge, MD PhD, Nicolas Falvo, MD, Matthieu Resche-Rigon, MD PhD, Toufek Berremili, MD, Francis Couturaud, MD PhD, Okba Bensaoula, MD, Lionel Védrine, MD, Isabelle Bonnet, MD, Denis Péré-Vergé, MD, Marie Coudurier, MD, Veronique Li, MD, Francis Cajfinger, MD

Blood (2016) 128 (22): 880.

https://doi.org/10.1182/blood.V128.22.880.880

Published: 2016

Journal Articles

Long-Term Use of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Patients’ Perception in Tropique, a Prospective, Multicenter, Observational Study

Dominique Farge, PhD MD, Philippe Debourdeau, MD, Norbert Claude Gorin, MD PhD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 4272.

https://doi.org/10.1182/blood.V124.21.4272.4272

Published: 2014

Journal Articles

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Philippe Debourdeau, MD, Norbert Claude Gorin, MD PhD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 4273.

https://doi.org/10.1182/blood.V124.21.4273.4273

Published: 2014

Journal Articles

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Norbert Claude Gorin, MD PhD, Philippe Debourdeau, MD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 1545.

https://doi.org/10.1182/blood.V124.21.1545.1545

Published: 2014

Journal Articles

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Blood (2008) 112 (11): 1284.

https://doi.org/10.1182/blood.V112.11.1284.1284

Published: 2008

NARROW

Quality of Life in Cancer Patients Undergoing Anticoagulant Treatment for Venous Thromboembolism: The Quavitec Study

Long-Term Use of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Patients’ Perception in Tropique, a Prospective, Multicenter, Observational Study

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Email alerts

ASH Publications

American Society of Hematology

Quality of Life in Cancer Patients Undergoing Anticoagulant Treatment for Venous Thromboembolism: The Quavitec Study

Long-Term Use of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Patients’ Perception in Tropique, a Prospective, Multicenter, Observational Study

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only